Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 609-462-3 | CAS number: 376653-37-1
Endpoint summary
Administrative data
Description of key information
BAL0001024, tested in DMF, did not show any sensitisation potential (non-sensitizer) in the Local Lymph Node Assay.
Key value for chemical safety assessment
Skin sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
The aim of this study was to determine the skin sensitisation potential of BAL0001024 following dermal exposure in mice.
A Preliminary Irritation/Toxicity Test was performed in CBA/CaOlaHsd mice using four doses (2 animals/dose): 100, 50, 25 and 10 % (w/v) in DMF and based on the results, 25 % (w/v) was selected as top dose for the main test.
In the main assay, twenty female CBA/CaOlaHsd mice were allocated to five groups, each group comprised four animals:
-groups (three) of animals received BAL0001024 (formulated in DMF) at either 25, 10 or 5 % (w/v),
-a negative control group received the vehicle (DMF) only,
-a positive control group received 25 % (w/v) HCA (dissolved in DMF). (To minimize animal use, the positive control was part of a parallel study (17/219-037E)
There was no mortality or signs of systemic toxicity observed during the study. A minimal amount of test item precipitate was observed on the ears of the 25 % (w/v) dose group animals from Day 2 up to Day 3 (4 out of the 4 animals).
No marked group mean body weight losses (≥5%) were observed in any groups.
The SI values were 0.7, 1.1 and 1.0 at concentrations of 25, 10 and 5 % (w/v), respectively.
In conclusion, under the conditions of the present assay, BAL0001024, tested in DMF, did not show any sensitisation potential (non-sensitizer) in the Local Lymph Node Assay.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
BAL0001024, tested in DMF, did not show any sensitisation potential (non-sensitizer) in the Local Lymph Node Assay.
No classification/labelling is triggered according to Regulation (EC) No 1272/2008 (CLP) / GHS (rev. 7) 2017.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
